First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Alkermes plc

    ALKS · 4 developments mapped · last assessed 2026-09-21

    Market Ontology has mapped 4 macro, policy, and market developments to Alkermes plc since 2026-08-12. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for ALKS yet, so no modelled value is shown. The ALKS valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run ALKS on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for ALKS. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Strongest support

      Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHD

      Direct positive clinical trial results for a pipeline asset, reducing R&D risk and increasing future revenue potential.

      · Moves probability of success for alks 7290, peak sales estimates for alks 7290, discount rate (reflecting reduced risk)

    • Open question

      Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors

      Governance improvement, strategic oversight, potential for enhanced decision-making and risk management.

      · Moves qualitative assessment of management and governance effectiveness, long term growth prospects (indirectly, through improved strategy)

    What changed, by assumption

    Probability of success for alks 7290
    • 2026-09-21Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHD
    Discount rate (cost of debt component)
    • 2026-08-12Alkermes plc. Announces Refinancing of Tranche B Term Loans and Repricing of Tranche A Term Loans
    Management quality
    • 2026-09-16Alkermes plc Appoints Anne C. Whitaker to Board of Directors
    Qualitative assessment of management and governance effectiveness
    • 2026-09-16Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors

    Assumption changes

    Full ledger →
    DateAssumptionDirectionWhyConf.
    2026-07-08Net debtBearishLiability-management transactions often reduce gross debt or push maturities out.0.70
    2026-07-08Interest expenseBearishTender/exchange extends maturity profile and typically lowers near-term interest expense.0.70

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-21Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHDBullish1-3m0.80
    2026-09-16Alkermes plc Appoints Anne C. Whitaker to Board of DirectorsBullish3-12m0.20
    2026-09-16Alkermes Announces Appointment of Anne C. Whitaker to Board of Directorswatch3-12m0.10
    2026-08-12Alkermes plc. Announces Refinancing of Tranche B Term Loans and Repricing of Tranche A Term LoansBullish1-3m0.70